Related Experiment Video
Updated: Jul 7, 2026
05:14
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Neuropsychiatric update: neuroimaging schizophrenia
1University of California, CA, USA.
Psychopharmacology Bulletin
|January 30, 2008
Summary
Neuroimaging studies reveal consistent brain structure and chemical differences in schizophrenia, including enlarged ventricles and altered dopamine activity. These findings link brain abnormalities to schizophrenia symptoms and guide future clinical applications.
Area of Science:
- Neuroscience
- Psychiatry
- Radiology
Background:
- Schizophrenia neurobiology research is advanced by neuroimaging techniques.
- Established neuroanatomical findings in schizophrenia include enlarged lateral ventricles and prefrontal abnormalities.
Purpose of the Study:
- To review neuroimaging modalities and findings in schizophrenia research.
- To correlate neuroimaging results with neuropathology and clinical symptoms.
- To discuss the clinical applications of neuroimaging in schizophrenia.
Main Methods:
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Positron Emission Tomography (PET)
- Single-Photon Emission Computed Tomography (SPECT)
- Functional MRI (fMRI)
- Diffusion Tensor Imaging (DTI)
Main Results:
- Consistent neuroanatomical findings: enlarged lateral ventricles, smaller superior temporal gyrus, prefrontal abnormalities.
- Neurochemical imaging supports dopaminergic dysregulation, aligning with the dopamine hypothesis.
- Neuroimaging findings correlate with clinical symptoms of schizophrenia.
Conclusions:
- Neuroimaging provides critical insights into the neurobiology of schizophrenia.
- Structural and neurochemical alterations are key features of the disorder.
- Neuroimaging holds significant potential for future clinical applications in schizophrenia management.
Related Concept Videos
01:14Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:17Schizophrenia
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.